Explore Fulcrum Therapeutics' 2024 financial report detailing revenue growth, reduced losses, and a strong liquidity position. Key insights on collaboration and profitability challenges.
Explore Fulcrum Therapeutics, Inc.'s 8-K filing detailing significant events, stock info, and essential company data for shareholders as of February 25, 2025.
Explore Fulcrum Therapeutics, Inc.'s latest 8-K filing from January 13, 2025. Stay informed on important updates affecting common stock (Ticker: FULC) and investor interests.
Explore Fulcrum Therapeutics' latest 8-K report detailing significant corporate events on December 18, 2024. Stay informed on SEC compliance and stock performance.